These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 148007)

  • 21. Sodium valproate in Huntington's disease.
    Symington GR; Leonard DP; Shannon PJ; Vajda FJ
    Am J Psychiatry; 1978 Mar; 135(3):352-4. PubMed ID: 147033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isoniazid-induced alteration of CSF neurotransmitter amino acids in Huntington's disease.
    Manyam BV; Ferraro TN; Hare TA
    Brain Res; 1987 Apr; 408(1-2):125-30. PubMed ID: 2885064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term treatment of juvenile Huntington's chorea with dipropylacetic acid.
    Bachman DS; Butler IJ; McKhann GM
    Neurology; 1977 Feb; 27(2):193-7. PubMed ID: 138101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolite levels in brain following experimental seizures: the effects of isoniazid and sodium valproate in cerebellar and cerebral cortical layers.
    McCandless DW; Feussner GK; Lust WD; Passonneau JV
    J Neurochem; 1979 Mar; 32(3):755-60. PubMed ID: 219147
    [No Abstract]   [Full Text] [Related]  

  • 25. Cerebrospinal fluid acetylcholinesterase and choline measurements in Huntington's disease.
    Manyam BV; Giacobini E; Colliver JA
    J Neurol; 1990 Aug; 237(5):281-4. PubMed ID: 2146369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative evaluation of functional capacity during isoniazid therapy in Huntington's disease.
    Stober T; Schimrigk K; Holzer G; Ziegler B
    J Neurol; 1983; 229(4):237-45. PubMed ID: 6192225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in 3H-GABA binding in Huntington's chorea.
    Lloyd KG; Dreksler S; Bird ED
    Life Sci; 1977 Sep; 21(5):747-53. PubMed ID: 198624
    [No Abstract]   [Full Text] [Related]  

  • 28. Huntington's chorea.
    Fisher RH; Norris JW; DeManuele F; Ridgley B; Malyon C
    Can Med Assoc J; 1982 Mar; 126(6):605-6. PubMed ID: 6461407
    [No Abstract]   [Full Text] [Related]  

  • 29. [Sleep in chronic chorea patients after therapy with sodium valproate].
    Puca FM; Genco S; Minervini MG; Specchio LM; Napoletano V; Brancasi B; Reggio F
    Boll Soc Ital Biol Sper; 1984 May; 60(5):989-92. PubMed ID: 6235824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Modern methods of treating Huntington's chorea].
    Kuran W
    Pol Tyg Lek; 1976 Aug; 31(32):1409-11. PubMed ID: 135971
    [No Abstract]   [Full Text] [Related]  

  • 31. [Symptomatic therapy in a possible animal model for Huntington's chorea].
    Schneider G; Oepen H; Klapproth A
    Arzneimittelforschung; 1981; 31(3):437-41. PubMed ID: 6452881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gamma-aminobutyric acid: drug-induced elevation in monkey brain.
    Perry TL; Urquhart N; Hansen S; Kennedy J
    J Neurochem; 1974 Aug; 23(2):443-5. PubMed ID: 4153580
    [No Abstract]   [Full Text] [Related]  

  • 33. Huntington's disease and HDACi: would sulpiride and valproate be of therapeutic value?
    Tremolizzo L; Rodriguez-Menendez V; DiFrancesco JC; Sala G; Galbussera A; Appollonio I; Ferrarese C
    Med Hypotheses; 2007; 69(4):964-5. PubMed ID: 17428619
    [No Abstract]   [Full Text] [Related]  

  • 34. [Recent neurobiological and related pharmaco-therapeutic acquisitions in Huntington's chorea].
    Carolei A; Del Castillo G
    Clin Ter; 1979 Sep; 90(6):591-621. PubMed ID: 43793
    [No Abstract]   [Full Text] [Related]  

  • 35. Improvement of Huntington's disease with olanzapine and valproate.
    Grove VE; Quintanilla J; DeVaney GT
    N Engl J Med; 2000 Sep; 343(13):973-4. PubMed ID: 11012330
    [No Abstract]   [Full Text] [Related]  

  • 36. Neurochemical substrates of rigidity and chorea in Huntington's disease.
    Storey E; Beal MF
    Brain; 1993 Oct; 116 ( Pt 5)():1201-22. PubMed ID: 7693298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of GABA metabolism: implications for Huntington's disease.
    Schwarcz R; Bennett JP; Coyle JT
    Ann Neurol; 1977 Oct; 2(4):299-303. PubMed ID: 152600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lumbar cerebrospinal fluid levels of GABA, HVA and 5HIAA in various patients with choreic movement and effects with isoniazid treatment].
    Yamamoto M; Otsuki S; Miyake K; Namba R
    No To Shinkei; 1983 May; 35(5):483-8. PubMed ID: 6194804
    [No Abstract]   [Full Text] [Related]  

  • 39. Valproate sodium in Huntington chorea.
    Pearce I; Heathfield KW; Pearce MJ
    Arch Neurol; 1977 May; 34(5):308-9. PubMed ID: 140642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rats chronically injected with urine from Huntington's chorea patients do not striatal damage.
    Perry TL; Hansen S; Kish SJ; MacLean J; Berry K
    Life Sci; 1981 Jun; 28(25):2869-74. PubMed ID: 6455580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.